Home > Insider Trading > Filing (0001104659-15-053991)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061027	Sunesis Pharmaceuticals Inc	SNSS	Pharmaceutical Preparations (2834)	943295878

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1323113	Jr N Daniel Swisher	C/O Sunesis Pharmaceuticals, Inc. 395 Oyster Point Blvd., Ste. 400 South San Francisco CA 94080	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-07-24	22,210	$1.32	151,346	No	4	X	Indirect	See footnote
Common Stock	Disposition	2015-07-24	8,477	$3.46	142,869	No	4	S	Indirect	See footnote
Common Stock	Acquisiton	2015-07-24	11,105	$1.32	153,974	No	4	X	Indirect	See footnote
Common Stock	Disposition	2015-07-24	4,238	$3.46	149,736	No	4	S	Indirect	See footnote
Common Stock	Acquisiton	2015-07-24	25,000	$1.02	174,336	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	X	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Disposition	2015-07-24	22,210	$0.00	22,210	$1.32
Common Stock	Warrant (right to buy)	Disposition	2015-07-24	11,105	$0.00	11,105	$1.32

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-04-03	2016-04-03	No	4	X	Indirect
0	2009-10-30	2016-10-30	No	4	X	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	179,510	Direct

Footnotes

The shares are held by the Swisher Revocable Trust for which reporting person is the Trustee.
On July 24, 2015, the reporting person exercised a warrant to purchase 22,210 shares of SNSS common stock for $1.32 a share. The reporting person paid the exercise price on a cashless basis, resulting in SNSS's withholding of 8,477 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 13,733 shares.
On July 24, 2015, the reporting person exercised a warrant to purchase 11,105 shares of SNSS common stock for $1.32 a share. The reporting person paid the exercise price on a cashless basis, resulting in SNSS's withholding of 4,238 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 6,867 shares.
The number of shares includes 3,686 shares that the reporting person acquired from an ESPP purchase on 5/29/15.